Running marathons or endurance races is often seen as a hallmark of peak fitness. However, a groundbreaking new study led by Inova oncologist Tim Cannon, MD, Sheridan Director, Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova Schar Cancer, reveals a surprising prevalence of precancerous colon growths among extreme runners. Recently featured in The New York Times, the study opens new discussions about screening opportunities.
Article links:
What is hsCRP, and how can it help predict your risk of developing heart disease?…
Recognition from U.S. News & World Report, Modern Healthcare and Press Ganey highlights Inova's commitment…
Raj Chand, MD, to serve as Interim President, Inova Loudoun Hospital Fairfax, VA — Inova is pleased to announce…
FDA-approved technology helps surgeons visualize ovarian cancer in real time during surgery FAIRFAX, Va. –…
Leesburg, VA — Inova Loudoun Hospital Mobile Health Services will be providing countywide blood pressure…
Study at a glanceInova’s incidental lung nodule program has shown a 76% reduction in time…